Risk-based lung cancer screening more cost-effective than age, smoking history-based screening Dr. Kamal Kant Kohli9 Feb 2023 8:00 PM ISTAn analysis of lung cancer screening methods found that risk-based lung cancer screening was more cost-effective than age and smoking history-based...
Ringlike peripheral high iodine concentration can differentiate lung cancer from pulmonary metastases: AJR Dr. Kamal Kant Kohli8 Feb 2023 9:30 AM ISTJapan: Ringlike peripheral high iodine concentration could help guide management in patients with known cancer and an indeterminate solitary nodule, a...
Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer Ruchika Sharma30 Jan 2023 2:45 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Medical Bulletin 23/January/2023 Isra Zaman23 Jan 2023 2:30 PM ISTHere are the top medical news for the day:Modified bacteria to tackle drug-resistant lung infectionsResearchers have designed the first ‘living...
Modified bacteria to tackle drug-resistant lung infections Isra Zaman23 Jan 2023 9:00 AM ISTResearchers have designed the first 'living medicine' to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria which...
Preexisting pulmonary fibrosis linked to negative outcomes after Lung resection Dr.Niharika Harsha B29 Dec 2022 8:00 PM ISTA new study found that the short and long-term outcomes in patients with pre-existing pulmonary fibrosis have worse outcomes post-lung resection;...
AstraZeneca gets Japanese approval for Imfinzi, Imjudo to treat 3 types of cancer Ruchika Sharma28 Dec 2022 11:30 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
Medical Bulletin 27/December/2022 Isra Zaman27 Dec 2022 2:45 PM ISTHere are the top medical news for the day:Novel bacterial therapy approach for treating lung cancerColumbia Engineering researchers report that they...
Novel bacterial therapy approach for treating lung cancer Isra Zaman27 Dec 2022 9:00 AM ISTColumbia Engineering researchers report thatthey have developed a preclinical evaluation pipeline for characterization ofbacterial therapies in lung...
FDA approves "glowing tumor" imaging agent Cytalux to aid lung cancer surgery Dr. Kamal Kant Kohli20 Dec 2022 9:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This...
Novartis gets CDSCO panel nod to study anticancer drug JDQ443 Dr. Divya Colin17 Dec 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Novartis, has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Submit Phase IV CT protocol: CDSCO Panel tells Roche over Anti-Cancer drug Pralsetinib Dr. Divya Colin16 Dec 2022 6:00 PM ISTNew Delhi: Reiterating the earlier recommendation regarding the condition of conduct a Phase IV clinical trial of anti-neoplastic drug Pralsetinib,...
